Cargando…

Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial

BACKGROUND: Food insecurity in sub-Saharan Africa and malnutrition constitute the main obstacles for successful treatment of people living with HIV/AIDS (PLWH). The aim of this study was to assess the effect of consuming daily 100 g RUTF (ready-to-use therapeutic food) as supplement, on body composi...

Descripción completa

Detalles Bibliográficos
Autores principales: Diouf, Adama, Badiane, Abdou, Manga, Noël Magloire, Idohou-Dossou, Nicole, Sow, Papa Salif, Wade, Salimata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700615/
https://www.ncbi.nlm.nih.gov/pubmed/26728978
http://dx.doi.org/10.1186/s12889-015-2639-8
_version_ 1782408348616884224
author Diouf, Adama
Badiane, Abdou
Manga, Noël Magloire
Idohou-Dossou, Nicole
Sow, Papa Salif
Wade, Salimata
author_facet Diouf, Adama
Badiane, Abdou
Manga, Noël Magloire
Idohou-Dossou, Nicole
Sow, Papa Salif
Wade, Salimata
author_sort Diouf, Adama
collection PubMed
description BACKGROUND: Food insecurity in sub-Saharan Africa and malnutrition constitute the main obstacles for successful treatment of people living with HIV/AIDS (PLWH). The aim of this study was to assess the effect of consuming daily 100 g RUTF (ready-to-use therapeutic food) as supplement, on body composition, anemia and zinc status of hospitalized PLWH in Senegal. METHODS: A Controlled clinical trial was conducted in 65 PLWH randomly allocated to receive either standard hospital diet alone (Control group: n = 33), or the standard diet supplemented with 100 g RUTF/day (RUTF group: n = 32). Supplementation was continued at home during 9 weeks. Individual dietary intakes were measured and compared to the Recommended Dietary Allowances. Body composition was determined using Bio-Impedance Analysis. Hemoglobin was measured by HemoCue and plasma zinc (PZ) concentration by atomic absorption spectrometry. PZ was adjusted to infection (CRP and α1-AGP). All measures were conducted on admission, discharge and after 9 weeks home-based follow up. RESULTS: 34 and 24 % of the patients in RUTF and Control groups were suffering from severe malnutrition (BMI < 16 kg/m(2)), respectively. In both groups, more than 90 % were anemic and zinc deficiency affected over 50 % of the patients. Food consumed by the Control group represented 75, 14 and 55 % of their daily recommended intake (DRI) of energy, iron and zinc, respectively. When 100 g of RUTF was consumed with the standard diet, the DRI of energy and zinc were 100 % covered (2147 kcal, 10.4 mg, respectively), but not iron (2.9 mg). After 9 weeks of supplementation, body weight, and fat-free mass increased significantly by +11 % (p = 0.033), and +11.8 % (p = 0.033) in the RUTF group, but not in the Control group, while percentage body fat was comparable between groups (p = 0.888). In the RUTF group, fat free mass gain is higher in the patients on ART (+11.7 %, n = 14; p = 0.0001) than in those without ART (+6.2 %, n = 6; p = 0.032). Anemia decreased significantly with the supplementation, but zinc status, measured using plasma zinc concentration, remained unchanged. CONCLUSION: Improving PLWH’ diet with 100 g RUTF for a long period has a positive impact on muscle mass and anemia but not on the zinc status of the patients. TRIAL NUMBER: NCT02433743, registered 29 April 2015.
format Online
Article
Text
id pubmed-4700615
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47006152016-01-06 Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial Diouf, Adama Badiane, Abdou Manga, Noël Magloire Idohou-Dossou, Nicole Sow, Papa Salif Wade, Salimata BMC Public Health Research Article BACKGROUND: Food insecurity in sub-Saharan Africa and malnutrition constitute the main obstacles for successful treatment of people living with HIV/AIDS (PLWH). The aim of this study was to assess the effect of consuming daily 100 g RUTF (ready-to-use therapeutic food) as supplement, on body composition, anemia and zinc status of hospitalized PLWH in Senegal. METHODS: A Controlled clinical trial was conducted in 65 PLWH randomly allocated to receive either standard hospital diet alone (Control group: n = 33), or the standard diet supplemented with 100 g RUTF/day (RUTF group: n = 32). Supplementation was continued at home during 9 weeks. Individual dietary intakes were measured and compared to the Recommended Dietary Allowances. Body composition was determined using Bio-Impedance Analysis. Hemoglobin was measured by HemoCue and plasma zinc (PZ) concentration by atomic absorption spectrometry. PZ was adjusted to infection (CRP and α1-AGP). All measures were conducted on admission, discharge and after 9 weeks home-based follow up. RESULTS: 34 and 24 % of the patients in RUTF and Control groups were suffering from severe malnutrition (BMI < 16 kg/m(2)), respectively. In both groups, more than 90 % were anemic and zinc deficiency affected over 50 % of the patients. Food consumed by the Control group represented 75, 14 and 55 % of their daily recommended intake (DRI) of energy, iron and zinc, respectively. When 100 g of RUTF was consumed with the standard diet, the DRI of energy and zinc were 100 % covered (2147 kcal, 10.4 mg, respectively), but not iron (2.9 mg). After 9 weeks of supplementation, body weight, and fat-free mass increased significantly by +11 % (p = 0.033), and +11.8 % (p = 0.033) in the RUTF group, but not in the Control group, while percentage body fat was comparable between groups (p = 0.888). In the RUTF group, fat free mass gain is higher in the patients on ART (+11.7 %, n = 14; p = 0.0001) than in those without ART (+6.2 %, n = 6; p = 0.032). Anemia decreased significantly with the supplementation, but zinc status, measured using plasma zinc concentration, remained unchanged. CONCLUSION: Improving PLWH’ diet with 100 g RUTF for a long period has a positive impact on muscle mass and anemia but not on the zinc status of the patients. TRIAL NUMBER: NCT02433743, registered 29 April 2015. BioMed Central 2016-01-04 /pmc/articles/PMC4700615/ /pubmed/26728978 http://dx.doi.org/10.1186/s12889-015-2639-8 Text en © Diouf et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Diouf, Adama
Badiane, Abdou
Manga, Noël Magloire
Idohou-Dossou, Nicole
Sow, Papa Salif
Wade, Salimata
Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
title Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
title_full Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
title_fullStr Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
title_full_unstemmed Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
title_short Daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with HIV/AIDS: a randomized controlled trial
title_sort daily consumption of ready-to-use peanut-based therapeutic food increased fat free mass, improved anemic status but has no impact on the zinc status of people living with hiv/aids: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700615/
https://www.ncbi.nlm.nih.gov/pubmed/26728978
http://dx.doi.org/10.1186/s12889-015-2639-8
work_keys_str_mv AT dioufadama dailyconsumptionofreadytousepeanutbasedtherapeuticfoodincreasedfatfreemassimprovedanemicstatusbuthasnoimpactonthezincstatusofpeoplelivingwithhivaidsarandomizedcontrolledtrial
AT badianeabdou dailyconsumptionofreadytousepeanutbasedtherapeuticfoodincreasedfatfreemassimprovedanemicstatusbuthasnoimpactonthezincstatusofpeoplelivingwithhivaidsarandomizedcontrolledtrial
AT manganoelmagloire dailyconsumptionofreadytousepeanutbasedtherapeuticfoodincreasedfatfreemassimprovedanemicstatusbuthasnoimpactonthezincstatusofpeoplelivingwithhivaidsarandomizedcontrolledtrial
AT idohoudossounicole dailyconsumptionofreadytousepeanutbasedtherapeuticfoodincreasedfatfreemassimprovedanemicstatusbuthasnoimpactonthezincstatusofpeoplelivingwithhivaidsarandomizedcontrolledtrial
AT sowpapasalif dailyconsumptionofreadytousepeanutbasedtherapeuticfoodincreasedfatfreemassimprovedanemicstatusbuthasnoimpactonthezincstatusofpeoplelivingwithhivaidsarandomizedcontrolledtrial
AT wadesalimata dailyconsumptionofreadytousepeanutbasedtherapeuticfoodincreasedfatfreemassimprovedanemicstatusbuthasnoimpactonthezincstatusofpeoplelivingwithhivaidsarandomizedcontrolledtrial